[Molecular pathogenesis of myeloma for the therapeutic targets].

Abstract excerpt

Multiple myeloma(MM) is a neoplasia of plasma cells in bone marrow. High dose chemotherapy followed by stem cell transplantation and new drugs such as thalidomide and bortezomib have improved the survival in MM. However, most of patients with myeloma are incurable so there is a need for the new therapeutic approaches that have been developed against molecular targets and pathway. It has been reported that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to Genome, Human
• Share to Multiple Myeloma